Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Net Margin: 2019-2025

Historic Net Margin for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -41.92%.

  • Biodesix's Net Margin rose 1666.00% to -41.92% in Q3 2025 from the same period last year, while for Sep 2025 it was -49.85%, marking a year-over-year increase of 1658.00%. This contributed to the annual value of -59.95% for FY2024, which is 4370.00% up from last year.
  • Per Biodesix's latest filing, its Net Margin stood at -41.92% for Q3 2025, which was up 27.77% from -58.03% recorded in Q2 2025.
  • Biodesix's Net Margin's 5-year high stood at -21.60% during Q1 2021, with a 5-year trough of -238.21% in Q1 2022.
  • In the last 3 years, Biodesix's Net Margin had a median value of -60.26% in 2025 and averaged -78.31%.
  • In the last 5 years, Biodesix's Net Margin surged by 17,226bps in 2021 and then plummeted by 21,661bps in 2022.
  • Quarterly analysis of 5 years shows Biodesix's Net Margin stood at -182.38% in 2021, then soared by 1,125bps to -171.13% in 2022, then spiked by 10,841bps to -62.71% in 2023, then skyrocketed by 2,159bps to -41.12% in 2024, then spiked by 1,666bps to -41.92% in 2025.
  • Its last three reported values are -41.92% in Q3 2025, -58.03% for Q2 2025, and -60.26% during Q1 2025.